Mesenchymal stem cells and their microenvironment

J Liu, J Gao, Z Liang, C Gao, Q Niu, F Wu… - Stem Cell Research & …, 2022 - Springer
Mesenchymal stem cells (MSCs), coming from a wide range of sources, have multi-
directional differentiation ability. MSCs play vital roles in immunomodulation, hematopoiesis …

Intervertebral disc degeneration—Current therapeutic options and challenges

A Samanta, T Lufkin, P Kraus - Frontiers in Public Health, 2023 - frontiersin.org
Degeneration of the intervertebral disc (IVD) is a normal part of aging. Due to the spine's
declining function and the development of pain, it may affect one's physical health, mental …

Extracellular vesicles as an emerging treatment option for intervertebral disc degeneration: therapeutic potential, translational pathways, and regulatory considerations

TJ DiStefano, K Vaso, G Danias… - Advanced …, 2022 - Wiley Online Library
Emergent approaches in regenerative medicine look toward the use of extracellular vesicles
(EVs) as a next‐generation treatment strategy for intervertebral disc (IVD) degeneration …

[HTML][HTML] Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy

X Zhang, Y Hu, P Cheng, H Zhou, X Chen… - … journal of medical …, 2021 - ncbi.nlm.nih.gov
Intervertebral disc (IVD) degeneration (IDD) is a multifactorial pathological process
associated with low back pain (LBP). The pathogenesis is complicated, and the main …

[HTML][HTML] Decellularized Disc Hydrogels for hBMSCs tissue-specific differentiation and tissue regeneration

Y Peng, X Qing, H Lin, D Huang, J Li, S Tian, S Liu… - Bioactive materials, 2021 - Elsevier
Tissue specificity, a key factor in the decellularized tissue matrix (DTM), has shown bioactive
functionalities in tuning cell fate—eg, the differentiation of mesenchymal stem cells. Notably …

The burden of low back pain in children and adolescents with overweight and obesity: from pathophysiology to prevention and treatment strategies

L Ambrosio, G Mazzuca, A Maguolo… - Therapeutic …, 2023 - journals.sagepub.com
Nonspecific low back pain (LBP) is one of the most common causes of disability, affecting all
individuals at least once in their lifetime. Such a condition is also becoming increasingly …

Mesenchymal stem/stromal cells derived from human and animal perinatal tissues—origins, characteristics, signaling pathways, and clinical trials

M Kulus, R Sibiak, K Stefańska, M Zdun… - Cells, 2021 - mdpi.com
Mesenchymal stem/stromal cells (MSCs) are currently one of the most extensively
researched fields due to their promising opportunity for use in regenerative medicine. There …

[HTML][HTML] Ion elemental-optimized layered double hydroxide nanoparticles promote chondrogenic differentiation and intervertebral disc regeneration of mesenchymal …

Z Wang, H Yang, X Xu, H Hu, Y Bai, J Hai, L Cheng… - Bioactive Materials, 2023 - Elsevier
Chronic low back pain and dyskinesia caused by intervertebral disc degeneration (IDD) are
seriously aggravated and become more prevalent with age. Current clinical treatments do …

Fucoidan-loaded nanofibrous scaffolds promote annulus fibrosus repair by ameliorating the inflammatory and oxidative microenvironments in degenerative …

Q Yu, F Han, Z Yuan, Z Zhu, C Liu, Z Tu, Q Guo… - Acta Biomaterialia, 2022 - Elsevier
Tissue engineering holds potential in the treatment of intervertebral disc degeneration (IDD).
However, implantation of tissue engineered constructs may cause foreign body reaction and …

Cell-based therapy in the treatment of musculoskeletal diseases

J Trapana, J Weinerman, D Lee… - Stem cells …, 2024 - academic.oup.com
A limited number of tissues can spontaneously regenerate following injury, and even fewer
can regenerate to a state comparable to mature, healthy adult tissue. Mesenchymal stem …